Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
AbbVie
ABBV
|
+$1.41B |
| 2 |
Eli Lilly
LLY
|
+$945M |
| 3 |
Exxon Mobil
XOM
|
+$890M |
| 4 |
RTX Corp
RTX
|
+$675M |
| 5 |
Verizon
VZ
|
+$660M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
+$1.81B |
| 2 |
Deutsche Bank
DB
|
+$1.49B |
| 3 |
Amgen
AMGN
|
+$1.06B |
| 4 |
Charles Schwab
SCHW
|
+$1.02B |
| 5 |
Broadcom
AVGO
|
+$965M |
Sector Composition
| 1 | Technology | 19.65% |
| 2 | Healthcare | 16.3% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Industrials | 10.89% |
| 5 | Financials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Diamondback Energy
FANG
$39.6B
| $185M | 0.06% |
1,523,289
-610,436
| -29% | -$74M |
|
227
Amphenol
APH
$145B
| $181M | 0.06% |
5,628,118
-12,496,846
| -69% | -$402M |
|
|
LGF.B
228
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $177M | 0.06% |
20,015,435
+7,883,456
| +65% | +$69.6M |
|
|
SRCL
229
DELISTED
Stericycle Inc
SRCL
| $176M | 0.05% |
4,019,153
-377,805
| -9% | -$16.6M |
|
230
Cognizant
CTSH
$33.8B
| $176M | 0.05% |
2,609,024
-8,010,567
| -75% | -$541M |
|
231
Electronic Arts
EA
$43.1B
| $174M | 0.05% |
1,432,528
+9,740
| +0.7% | +$1.18M |
|
232
Alibaba
BABA
$370B
| $172M | 0.05% |
+1,509,110
| New | +$172M |
|
233
Suncor Energy
SU
$50.6B
| $171M | 0.05% |
4,862,043
+3,164
| +0.1% | +$111K |
|
|
IBTX
234
DELISTED
Independent Bank Group, Inc.
IBTX
| $166M | 0.05% |
2,446,602
-596,380
| -20% | -$40.5M |
|
235
Shell
SHEL
$207B
| $162M | 0.05% |
3,090,256
-1,684,448
| -35% | -$88.1M |
|
236
Pegasystems
PEGA
$9.93B
| $161M | 0.05% |
6,736,102
+2,451,008
| +57% | +$58.6M |
|
237
Matsons
MATX
$3.29B
| $157M | 0.05% |
2,157,874
+53,000
| +3% | +$3.86M |
|
238
SentinelOne
S
$6.13B
| $156M | 0.05% |
6,692,881
+314,783
| +5% | +$7.34M |
|
239
DraftKings
DKNG
$21.8B
| $156M | 0.05% |
13,372,787
+5,741,987
| +75% | +$67M |
|
240
Bank of America
BAC
$375B
| $154M | 0.05% |
4,957,015
-4,637,381
| -48% | -$144M |
|
|
HCP
241
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $153M | 0.05% |
5,205,998
+3,721,626
| +251% | +$110M |
|
242
Pfizer
PFE
$136B
| $152M | 0.05% |
2,902,264
+1,397,525
| +93% | +$73.3M |
|
243
BWX Technologies
BWXT
$15.4B
| $151M | 0.05% |
2,738,732
+105,898
| +4% | +$5.83M |
|
244
West Pharmaceutical
WST
$18.2B
| $150M | 0.05% |
494,635
+155
| +0% | +$46.9K |
|
245
Johnson & Johnson
JNJ
$429B
| $147M | 0.05% |
827,157
-222
| -0% | -$39.4K |
|
246
CONMED
CNMD
$1.64B
| $147M | 0.05% |
1,530,589
+391,233
| +34% | +$37.5M |
|
247
Euronet Worldwide
EEFT
$3.6B
| $144M | 0.04% |
1,431,928
+309,926
| +28% | +$31.2M |
|
248
British American Tobacco
BTI
$123B
| $142M | 0.04% |
3,310,449
+6,489
| +0.2% | +$278K |
|
249
PagSeguro Digital
PAGS
$2.78B
| $142M | 0.04% |
13,850,878
-17,367,576
| -56% | -$178M |
|
|
B
250
Barrick Mining Corporation
B
$49.5B
| $132M | 0.04% |
7,486,475
+846
| +0% | +$15K |
|